HomePHAT • NASDAQ
Follow
Phathom Pharmaceuticals Inc
Previous close
$11.05
Day range
$10.42 - $11.22
Year range
$6.07 - $17.02
Market cap
621.03M USD
Avg Volume
1.07M
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
(USD) | Dec 2023info | Y/Y change |
---|---|---|
Revenue | 682.00K | — |
Operating expense | 70.39M | 50.92% |
Net income | -79.57M | -44.55% |
Net profit margin | -11.67K | — |
Earnings per share | -0.80 | 39.85% |
EBITDA | -69.69M | -49.95% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
(USD) | Dec 2023info | Y/Y change |
---|---|---|
Cash and short-term investments | 381.39M | 145.45% |
Total assets | 413.84M | 151.10% |
Total liabilities | 486.60M | 103.07% |
Total equity | -72.76M | — |
Shares outstanding | 58.48M | — |
Price to book | -8.77 | — |
Return on assets | -53.68% | — |
Return on capital | -60.05% | — |
Cash Flow
Net change in cash
(USD) | Dec 2023info | Y/Y change |
---|---|---|
Net income | -79.57M | -44.55% |
Cash from operations | -43.80M | -6.72% |
Cash from investing | -475.00K | -15.29% |
Cash from financing | 211.99M | — |
Net change in cash | 167.72M | 504.61% |
Free cash flow | -19.87M | 29.33% |
About
Founded
2018
Headquarters
Website
Employees
452